Showing results (131-140 of 781) with videos related to
Sort By:
Pageof 79
Blood|April 30, 2016
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironmentYu-Tzu Tai, Chirag Acharya, Gang An, et al.Blood|July 24, 2010
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myelomaGüllü Görgün, Elisabetta Calabrese, Ender Soydan, et al.Blood|November 9, 2002
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applicationsNicholas Mitsiades, Constantine S Mitsiades, Paul G Richardson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 ExpressionLijie Xing, Su Wang, Jiye Liu, et al.Blood|April 9, 2004
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistanceDharminder Chauhan, Guilan Li, Klaus Podar, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2009
Epigenetic modulation in hematologic malignancies: challenges and progressConstantine S Mitsiades, Kenneth C AndersonClinical Advances in Hematology & Oncology : H&O|November 1, 2005
Bortezomib: a novel therapy approved for multiple myelomaPaul G Richardson, Kenneth C AndersonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
New strategies in the treatment of multiple myelomaNikhil C Munshi, Kenneth C AndersonMolecular Cancer Therapeutics|January 9, 2003
Synopsis of a research roundtable presented on cell signaling in myeloma: regulation of growth and apoptosis--opportunities for new drug discoveryKenneth C Anderson, William S DaltonSeminars in Oncology|February 19, 2005
Role of liposomal anthracyclines in the treatment of multiple myelomaMohamad A Hussein, Kenneth C AndersonPageof 79